February 2018
Procore initiates a comprehensive, post-marketing, controlled clinical trial in five leading medical centers in Israel
Procore initiated a new clinical trial in collaboration with five leading medical centers in Israel, including Sourasky Medical Center (Ichilov), Assaf Ha’Rofeh Medical Center, Hadassah Medical Center, Meir Hospital and Sha’arei Tzedek Medical Center. This comprehensive post-marketing trial will provide first-level evidence to support efficacy of RegenoGel in alleviating pain and restoring joint function, as well as a comprehensive comparison between the different products and their treatment protocols. Leading orthopedists and rheumatologists are taking part in the trial.